Literature DB >> 10208773

A homologous radioimmunoassay for the measurement of urotensin II in the euryhaline flounder, Platichthys flesus.

M J Winter1, P C Hubbard, C R McCrohan, R J Balment.   

Abstract

A sensitive and specific homologous radioimmunoassay (RIA) has been developed to measure tissue and circulating levels of the fish caudal neurosecretory system neuropeptide, urotensin II (UII), in the euryhaline flounder Platichthys flesus. A polyclonal antiserum was raised against flounder UII in rabbit; UII-125I was produced by the iodogen method and purified by HPLC. Antiserum specificity to flounder UII was demonstrated through lack of cross-reactivity with several small peptides and parallelism with standard curves for serial dilutions of UII in plasma and urophysial extracts. Biological activity of the peptide measured by UII RIA was confirmed by bioassay. Plasma intra- and interassay coefficients of variation were 9 and 18% (n = 5 and n = 3), respectively, nonspecific binding constituted 4.6% (+/-1.42%, n = 8) of total counts, and the limit of RIA detectability was estimated as 1.5 x 10(-16) M UII/assay tube. Plasma samples were subject to a reversed-phase liquid chromatography purification protocol which had an extraction efficiency of 63% (+/-10%, n = 6) and showed consistent recovery of UII over a range of plasma volumes and peptide concentrations. Plasma UII concentrations in seawater (SW)-adapted flounder (3.80 +/- 0.77 x 10(-11) M, n = 7) were significantly higher than those in freshwater (FW)-adapted fish (1.10 +/- 0.15 x 10(-11) M, n = 7). This variation coincided with differences in plasma osmolality and Na+ levels. No differences were found, however, between urophysial UII concentrations in SW-adapted (3.71 +/- 1.78 x 10(-10) M UII/gland, n = 7) and FW-adapted (2.53 +/- 1.33 x 10(-10) M UII/gland, n = 7) flounder. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208773     DOI: 10.1006/gcen.1998.7245

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  7 in total

1.  Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey.

Authors:  S A Douglas; A C Sulpizio; V Piercy; H M Sarau; R S Ames; N V Aiyar; E H Ohlstein; R N Willette
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Calcium-sensing receptors and parathyroid hormone-related protein in the caudal neurosecretory system of the flounder (Platichthys flesus).

Authors:  P M Ingleton; L A Bendell; J A Flanagan; C Teitsma; R J Balment
Journal:  J Anat       Date:  2002-05       Impact factor: 2.610

Review 3.  Is urotensin-II the new endothelin?

Authors:  Janet J Maguire; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.

Authors:  Nabil A Elshourbagy; Stephen A Douglas; Usman Shabon; Stephen Harrison; Graham Duddy; Jan L Sechler; Zhaohui Ao; Beverly E Maleeff; Diane Naselsky; Jyoti Disa; Nambi V Aiyar
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.

Authors:  Jonathan T Affolter; David E Newby; Ian B Wilkinson; Matthew J Winter; Richard J Balment; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

6.  Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat.

Authors:  Heather J Eyre; Thomas Speight; Jocelyn D Glazier; David M Smith; Nick Ashton
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

7.  The urotensin system is up-regulated in the pre-hypertensive spontaneously hypertensive rat.

Authors:  Ellen J Forty; Nick Ashton
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.